Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects
Stopped Low enrollment rate
Conditions
- Secondary Hyperparathyroidism
- Dialysis
Interventions
- DRUG: Calcitriol
- DRUG: Paricalcitol
Sponsor
Abbott
Collaborators